However, Yamaguchi et al. reported that GDF15 exerts anti-tumorigenic and pro-apoptotic effects in CRC cell lines, with its expression regulated by the PI3K/AKT/GSK-3β pathway, where AKT inhibition of GSK-3β promotes GDF15 expression [90]. This evidence concerns the gene AKT1 and colorectal carcinoma.